Search results
Innovent’s mazdutide superior to Trulicity in Phase III T2D trial
Clinical Trials Arena via Yahoo Finance· 1 month agoInnovent Biologics has said that its type 2 diabetes (T2D) candidate mazdutide was superior to Eli...
J&J’s Tremfya superior to Stelara in Phase II/III Chron’s disease trials
Clinical Trials Arena via Yahoo Finance· 1 month agoJohnson and Johnson’s Johnson and Johnson’s Tremfya (guselkumab) was superior to its Stelara...
Exeliom to focus on gastric cancer landscape with immune modulating drug
Clinical Trials Arena via Yahoo Finance· 2 months agoParis-based Exeliom Biosciences will focus Phase III efforts of its immune modulating drug EXL01 in...
Tapinarof may mark Dermavant’s first atopic dermatitis approval
Clinical Trials Arena via Yahoo Finance· 1 week agoFollowing the recent positive results of the Phase III clinical trial for Dermavant’s VTAMA...
J&J’s seltorexant meets all endpoints in Phase III MDD trial
Clinical Trials Arena via Yahoo Finance· 3 weeks agoJohnson & Johnson (J&J) has announced that its seltorexant medication met all the primary and...
Insmed stocks soar as Phase III lung disease drug exceeds expectations
Clinical Trials Arena via Yahoo Finance· 3 weeks agoInsmed’s stocks more than doubled after the company announced its lead-pipeline candidate...
Trials to watch: Four ALS drugs to keep an eye on
Clinical Trials Arena via Yahoo Finance· 2 months agoIt has been a turbulent few weeks for patients with amyotrophic lateral sclerosis (ALS) after Amylyx Pharmaceuticals pulled its lead drug Relyvrio from...
GSK boasts win for depemokimab in asthma trials
Clinical Trials Arena via Yahoo Finance· 1 month agoGSK has announced positive data from two Phase III trials of its asthma candidate depemokimab. The pharma giant announced the drug met primary endpoints...
Regenex Bio eyes FDA meeting to confirm pivotal DMD trial
Clinical Trials Arena via Yahoo Finance· 1 month agoRegenex Bio has announced it is meeting with the US Food and Drug Administration (FDA) with plans to...
The top pharmaceutical companies by R&D expenditure
Pharmaceutical Technology via Yahoo Finance· 2 months agoThe year 2023 marked a significant change in the pharmaceutical industry’s landscape as investment in Covid-19 lost prominence in the aftermath of the...
